NCT00030082View on ClinicalTrials.gov

Hepatic Arterial Infusion With Melphalan in Treating Patients With Unresectable Liver Cancer

PHASE1CompletedINTERVENTIONAL
Timeline

Start Date

July 31, 2001

Conditions
Liver CancerMetastatic Cancer
Interventions
DRUG

isolated perfusion

DRUG

melphalan

Trial Locations (1)

20892-1182

Warren Grant Magnuson Clinical Center - NCI Clinical Studies Support, Bethesda

All Listed Sponsors
lead

National Cancer Institute (NCI)

NIH

NCT00030082 - Hepatic Arterial Infusion With Melphalan in Treating Patients With Unresectable Liver Cancer | Biotech Hunter | Biotech Hunter